Feminor 5Mg


Feminor 5Mg


Stock Status:

In Stock

  • *Upload Prescription

    • (max file size 80 MB)



Norethisterone Acetate



Metropathia hemorrhagic (dysfunctional uterine hemorrhage), Premenstrual syndrome, Postponement of menstruation, Endometriosis, and Menorrhagia are among conditions where Norethisterone is prescribed.



Norethisterone tablet is a Norethisterone formulation that exhibits progestational effects similar to progesterone, but is a more effective ovulation inhibitor and has modest estrogenic and androgenic activities. It is used to treat a variety of menstrual cycle abnormalities. Norethisterone is absorbed through the gastrointestinal system and has a 24-hour duration of action. It is eliminated through the urine.


Dosage & Administration

Oral administration. Not intended for use in children.

Metropathia haemorrhagica (dysfunctional uterine bleeding): 1 tablet 3 times daily for 10 days. Bleeding is arrested usually within 1-3 days. A withdrawal bleeding resembling normal menstruation occurs within 2-4 days after discontinuing treatment.

Prophylaxis against recurrence of dysfunctional bleeding: If there are no signs of resumption of normal ovarian function (no rise in the second half of the cycle of the morning temperature, which should be measured daily) recurrence must be anticipated. Cyclical bleeding can be established with 1 tablet twice daily from the 19th to the 26th day of the cycle.

Premenstrual syndrome (including premenstrual mastalgia): Premenstrual symptoms such as headache, migraine, breast discomfort, water retention, tachycardia, and psychological disturbances may be relieved by the administration of 2-3 tablets daily from the 19th to the 26th day of the cycle. Treatment should be repeated for several cycles. When treatment is stopped, the patient may remain symptom-free for a number of months.

Postponement of menstruation: In cases of too frequent menstrual bleeding, and in special circumstances (e.g. operations, travel, sports) the postponement of menstruation is possible. 1 tablet of Norethisterone three times daily, starting 3 days before the expected onset of menstruation. A normal period should occur 2-3 days after the patient has stopped taking tablets.

Endometriosis (pseudo-pregnancy therapy): Long-term treatment is commenced on the 5th day of the cycle with 2 tablets of Norethisterone daily for the first few weeks. In the event of spotting, the dosage is increased to 4, and, if necessary, 5 tablets daily. After bleeding has ceased, the initial dose is usually sufficient. Duration of treatment: 4-6 months continuously, or longer if necessary.

Menorrhagia (hypermenorrhoea): 1 tablet 2-3 times a day from the 19th to the 26th day of the cycle (counting the first day of menstruation as day 1).



Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor or pharmacist first.Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of: drugs affecting liver enzymes that remove norethindrone from your body (such as rifampin, St. John’s wort, azole antifungals including itraconazole, certain anti-seizure medicines including carbamazepine/phenobarbital/phenytoin).This medication can affect the results of certain lab tests. Make sure laboratory personnel and all your doctors know you use this medication.

This document does not contain all possible interactions. Therefore, before using this product, tell your doctor or pharmacist of all the products you use. Keep a list of all your medications with you, and share the list with your doctor and pharmacist.



  • Pregnancy
  • Disturbances in liver function that are severe
  • The Dubin-Johnson syndrome is a condition that affects a person’s
  • Rotor syndrome is a condition in which the rotor
  • Idiopathic jaundice, severe pruritus, or herpes gestationis during pregnancy Previous or existing liver
  • tumors Current thromboembolic processes
  • Hypersensitivity to any of the active ingredients or excipients


Side Effects

  • Side effects are more likely in the first few months after starting Norethisterone medication, although they fade over time.
  • The following are some of the adverse effects:
  • Visual disturbances are caused by eye problems.
  • GI problems, Vomiting
  • Disorders in general and conditions at the administration site edema, headache
  • Migraine, respiratory, thoracic, and mediastinal illnesses are examples of nervous system disorders.
  • – Dyspnoea, as well as skin and subcutaneous tissue diseases- Hypersensitivity to stimuli (eg. rash, urticaria).


Pregnancy & Lactation

The administration of Norethisterone during pregnancy is contraindicated. Norethisterone should not be used during lactation.


Precautions & Warnings

There is a general opinion, based on statistical evidence that users of combined oral contraceptives experience, more often than non-users, venous thromboembolism, arterial thrombosis, including cerebral and myocardial infarction and subarachnoid haemorrhage. Full recovery from such disorders does not always occur, and it should be realized that in a few cases they are fatal. Although Norethisterone does not contain oestrogen, one should keep the possibility of an increased thromboembolic risk in mind, particularly where there is a history of thromboembolic disease or in the presence of severe diabetes with vascular changes or sickle-cell anaemia.


Therapeutic Class

Hormone replacement therapy, female sex hormones, and oral contraceptive preparations are some of the medications used to treat menopausal symptoms.


Storage Conditions

Protect from light and moisture by storing in a cool, dry place below 30°C. Keep out of children’s reach.


Pharmaceutical Name

ACME Laboratories Ltd.